相关实验视频
Updated: Jun 13, 2025

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
8.1K
尼比沃醇化及其杂质通过巨细胞激活诱导伪过敏反应
Liju Yu1,2, Yi Shan1, Jiayu Lu1
1School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, 710061, China.
Journal of applied toxicology : JAT
|September 17, 2024
概括
尼比沃洛及其杂质可以通过激活巨细胞来引发过敏反应,这是一个涉及MRGPRX2受体的途径. 这项研究澄清了因内比沃醇引起的过敏症背后的机制,为更安全的心血管治疗铺平了道路.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 药用化学 医学化学
背景情况:
- 尼比沃洛化是一种第三代β抑制剂,广泛用于心血管疾病.
- 临床观察表明,nebivolol可以诱导过敏反应,需要进一步研究其潜在机制.
研究的目的:
- 调查nebivolol异构体和奇拉杂质诱发过敏反应的潜力.
- 阐明与Mas相关的G蛋白结合受体X2 (MRGPRX2) 在因内比沃醇引起的过敏症中的作用.
主要方法:
- 在实验室中进行巨细胞脱粒试验.
- 与Mas相关的G蛋白结合受体X2 (MRGPRX2) -HEK293细胞膜染色学.
- 对过敏反应 (脚胀) 的体内小鼠模型.
- 分子对接模拟. 分子对接模拟.
主要成果:
- 尼比沃洛及其同位素杂质在体外激活了巨细胞脱粒化.
- 化合物显示显著结合MRGPRX2,通过细胞膜染色学证实.
- 在体内研究表明,nebivolol和杂质IP-3在小鼠中诱导了脚的胀和巨细胞脱粒.
- 分子对接揭示了nebivolol/杂质和MRGPRX2.2.之间的直接相互作用.
结论:
- 尼比沃洛和特定的杂质可以通过MRGPRX2激活诱导过敏反应.
- 这些发现为因尼比沃醇引起的过敏症提供了机制的基础.
- 这项研究有助于提高nebivolol的临床安全性.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
246
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
246
Allergic Reactions
27.3K
Overview
27.3K
Allergic Drug Reactions
821
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
821
Adrenergic Antagonists: ɑ and β-Receptor Blockers
420
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
420
Adrenergic Agonists: Mixed-Action Agents
690
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
690
Antiasthma Drugs: β2-Adrenoceptor Agonists
239
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
239

